Mechanical-controlled drug release

In particular, rotaxane dendrimers capable of reversible binding of ring and rod components, such as Type II, pseudorotaxane-terminated dendrimers, can be reversibly controlled by external stimuli, such as the solvent composition, temperature, and pH, to change their structure and properties. This has profound implications in diverse applications, for instance in the controlled drug release. A trapped guest molecule within a closed dendrimeric host system can be unleashed in a controlled manner by manipulating these external factors. In the type III-B rotaxane dendrimers, external stimuli can result in perturbations of the interlocked mechanical bonds. This behavior can be gainfully exploited to construct controlled molecular machines. 

Silicones are frequently used in transdermal drug delivery. Recently, the use of loosely cross-linked silicone elastomer blends for this application was surveyed.537 The mechanisms of controlled drug release in the silicone-based systems have been studied,538 as silicones are evaluated for relatively new protein drug-delivery systems.5... 

Acharya G, Park K. Mechanisms of controlled drug release from drug-eluting stents. Adv Drug Deliv Rev 2006 58(3) 387—401. 

Equation (6.94) illustrates that zero-order release kinetics are obtained if drug dissolution controls the release kinetics. However, as soon as the last particle in the matrix dissolves, the controlling mechanism of drug release shifts to Fickian diffusion. Figure 6.19 shows the dissolution-controlled release of KC1 at the early stage of release and the diffusion-controlled release at the later stage of release from an ethyl cellulose tablet. 

This arbitrary recommendation does not rely on strict theoretical and experimental findings and is based only on the fact that completely different physical conditions have been postulated for the derivation of the equivalent (4.2) and (4.3), while the underlying mechanism in both situations is classical diffusion. In this context, a linear plot of the cumulative amount of drug released q (t) or the fraction of drug released q (f) /f/,Xj (utilizing data up to 60% of the release curve) vs. the square root of time is routinely used in the literature as an indicator for diffusion-controlled drug release from a plethora of delivery systems. 

Perez-Marcos B, Iglesias R, Gomez-Amoza JL, et al. Mechanical and drug-release properties of atenolol-carbomer hydrophilic matrix tablets. / Control Release 1991 17 267-276. 

Yuzhakov et al. [93] describe the production of an intracutaneous microneedle array and provide an account of its use (microfabrication technology). Various embodiments of this invention can include a microneedle array as part of a closed loop system smart patch to control drug delivery based on feedback information from analysis of body fluids. Dual purpose hollow microneedle systems for transdermal delivery and extraction which can be coupled with electrotransport methods are also described by Trautman et al. [91] and Allen et al. [100]. These mechanical microdevices which interface with electronics in order to achieve a programmed or controlled drug release are referred to as microelectromechanical systems (MEMS) devices. 

Biodegradable materials were initially used in medical applications such as sutures, prostheses, controlled drug-release systems, and vascular grafts. These applications are enabled by their biocompatibility, their ability to be absorbed by the body, and because of their mechanical properties appropriate for such applications [6]. 

---